Observational studyBlood advances2025

Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Antonio Gutierrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.